Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. Shirali
Pdb15 - Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors: Systematic Literature Review and Indirect Comparisons
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Dipeptidyl Peptidase-4 (DPP-4; CD26)
Science-Business eXchange
Pdb12 - Cardiovascular Safety of Empagliflozin Versus Glucagon-Like Peptide-1 (Glp-1) Receptor Agonists: Systematic Literature Review and Indirect Comparisons
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-Lowering Therapies for Three Acute Outcomes
Scientific Reports
Multidisciplinary
Navigating the Chemical Space of Dipeptidyl Peptidase-4 Inhibitors
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Effectiveness in Clinical Practice Versus Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Clinical Trials for Type 2 Diabetes: Protocol for Systematic Review
BMJ Open
Medicine
Hydrolytic Metabolism of Cyanopyrrolidine DPP-4 Inhibitors Mediated by Dipeptidyl Peptidases
Drug Metabolism and Disposition
Pharmacology
Pharmaceutical Science
Systematic Literature Review of DPP-4 Inhibitors in Patients With Type 2 Diabetes Mellitus and Renal Impairment
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
